Navamedic ASA

Price Chart

Risk-Adjusted Performance

Navamedic ASA (NAVA) Price Performance

Navamedic ASA (NAVA) trades on Oslo Stock Exchange in NOK. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at NOK21.70, up 1.40% from the previous close.

Over the past year, NAVA has traded between a low of NOK19.40 and a high of NOK26.40. The stock has gained 4.3% over this period. It is currently 17.8% below its 52-week high.

Navamedic ASA has a market capitalization of $520.40M.

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases, fat metabolism, renal, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; prescription medicines covering obesity, Parkinson's disease, urology, and cardiology; and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is based in Oslo, Norway.